ROCHE HEMOGLOBIN A1C CONTROL N AND CONTROL P— 510(k) K972721

Name: FDA 510(k) clearance K972721
Creator: U.S. Food and Drug Administration
Published: 1997-08-06

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K972721 for ROCHE HEMOGLOBIN A1C CONTROL N AND CONTROL P, Substantially Equivalent on 1997-08-06. Applicant: Roche Diagnostic Systems, Inc.. Device class: 1.

Clearance details

Applicant: Roche Diagnostic Systems, Inc.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1997-07-21
Decision date: 1997-08-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Branchburg, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Roche Diagnostic Systems, Inc.

view all

K983698 — MODIFICATION TO ABUSCREEN ONLINE BARBITURATES1999-05-03
K983702 — MODIFICATION TO ABUSCREEN ONLINE FOR BENZOIDIAZEPINES1999-02-11
K983704 — MODIFICATION TO ABUSCREEN ONLINE FOR PHENCYCLIDINE1999-02-10
K983555 — ABUSCREEN ONLINE BENZ 200 CALIBRATORS1998-12-15
K983556 — ABUSCREEN ONLINE BENZ 300 CALIBRATORS1998-12-15

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.